Despite Maccura Biotechnology's strong earnings outlook and ...

Despite Maccura Biotechnology's strong earnings outlook and rapid growth forecast, its low P/E ratio indicates investor skepticism. Potential risks may be exerting significant pressure on the P/E ratio.